Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-03-30
1994-03-22
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514887, 514546, 514859, 514777, 514778, 514844, 514846, 530833, 424 47, 424 70, 424 71, 424DIG13, 536103, A61K 3170, A61K 31715
Patent
active
052964728
ABSTRACT:
This invention relates to methods for delipidation of skin or hair through the use of cyclodextrins and cyclodextrin derivatives such as hydroxypropyl .beta.-cyclodextrin. The invention also relates to cerumen removal methods involving introduction of cyclodextrins to the ear canal, followed by complexation of the cyclodextrin with cerumen components, and removal of the resulting cyclodextrin complexes. The cyclodextrin components are used in a substantially oil-free powdered or aqueous formulation without detergents, soaps, solvents, oils or other lipid-like agents.
REFERENCES:
patent: 4267166 (1981-05-01), Yajima
patent: 4352794 (1982-10-01), Koch
patent: 4507319 (1985-03-01), Barratt et al.
patent: 4678598 (1987-07-01), Ogino et al.
patent: 4869904 (1989-09-01), Uekama et al.
patent: 4891361 (1990-01-01), Hatae
patent: 4970072 (1990-11-01), Honda et al.
patent: 5026551 (1991-06-01), Yorozu et al.
patent: 5086050 (1992-02-01), Hettche et al.
Szejtli, J. (1985) "Cyclodextrins: A new group of industrial basic materials" Die Nahrung 9:911-924.
Pitha, Josef (1987) "Amorphous Water Soluble Derivatives of Cyclodextrins: From Test Tube to Patient" Journal of Controlled Release 6:309-313.
Pitha, Josef, et al. (1988) "Drug Solubilizers To Aid Pharmacologists: Amorphous Cyclodextrin Derivatives" Life Sciences 43:493-502.
Irie, Tetsumi et al. (1988) "Amorphous Water-Soluble Cyclodextrin Derivatives: 2-Hydroxyethyl, 3- Hydroxypropyl, 2-Hydroxyisobutyl, and Carboxamidomethyl Derivatives of .beta.-Cyclodextrin" Pharmaceutical Research 5(11):713-717.
Pitha, Joseph (1989) "Cyclodextrins: Solutions To Insolubility" Neurotransmissions V(1):1-4 (published by Research Biochemicals Incorporated, Natick, Massachusetts).
Stern, Warren C. (1989) "Cyclodextrin-Based Drug Delivery" Drug News and Perspectives 2(7):410-415.
Strattan, Charles E. (1989) "Cyclodextrin-Based Drug Delivery" Pharmaceutical Manufacturing International, pp. 203-210.
Strattan, Charles E. (1991) "Chemically Modified Cyclodextrins" Pharmaceutical Manufacturing International, pp. 161-163.
Stratten, Charles E. (Nov./Dec. 1991) "Cyclodextrins and Biological Macromolecules", BioPharm pp. 44-51.
*"Gamma W8- Cyclodextrins and Derivatives", Wacker Chemicals, Promotional Literature Jun. 1990.
Uekama, "Cyclodextrin Inclusion Compounds: Effects on Stability and Bio-Pharmaceutical Properties", pp. 181-194, Elsevier Science Publishers B.V. (Biomedical Division) Topics in Pharmaceutical Sciences 1987, D. D. Breimer and P. Speiser, editors.
Hendler Sheldon S.
Sanchez Robert A.
Gates Stephen
Griffin Ronald W.
Hendricks Glenna
Vyrex Corporation
LandOfFree
Methods for delipidation of skin and cerumen removal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for delipidation of skin and cerumen removal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for delipidation of skin and cerumen removal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437195